SLS

SELLAS Life Sciences Group (SLS)

About SELLAS Life Sciences Group (SLS)

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

Details

Daily high

$2.42

Daily low

$2.22

Price at open

$2.32

52 Week High

$2.48

52 Week Low

$0.85

Market cap

336.2M

Dividend yield

0.00%

Volume

8.9M

Avg. volume

5.5M

P/E ratio

-8.23

SELLAS Life Sciences Group News